Abiopharma

Clinical trial NCT02651662 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-31 → 2026-04-29 3. primary completion date: 2026-05-31 → 2026-04-29

Clinical trial NCT01692886: start date: 2012-08-01 → 2012-09-01.

Clinical trial NCT06450197: primary completion date: 2026-05-01 → 2026-04-30.

Clinical trial NCT06018337 updates: 1. completion date: 2028-07-01 → 2028-08-01 2. primary completion date: 2026-05-01 → 2026-06-01

Arch Capital Group Ltd. Announces Cash Tender Offers to Purchase up to a Capped Amount of Certain of Its Subsidiaries’ Debt Securities

Notification from Dominari Holdings Inc

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-06-02 <b>AccNo:</b> 0001918704-26-015146 <b>Size:</b> 440 KB

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-06-02 <b>AccNo:</b> 0001918704-26-015145 <b>Size:</b> 108 KB

New Form SCHEDULE 13G - FG Merger II Corp. <b>Filed:</b> 2026-06-02 <b>AccNo:</b> 0002138061-26-000001 <b>Size:</b> 6 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-06-02 <b>AccNo:</b> 0001839882-26-027301 <b>Size:</b> 386 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-06-02 <b>AccNo:</b> 0001839882-26-027299 <b>Size:</b> 262 KB

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-06-02 <b>AccNo:</b> 0000950103-26-008273 <b>Size:</b> 192 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-06-02 <b>AccNo:</b> 0001839882-26-027297 <b>Size:</b> 579 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-06-02 <b>AccNo:</b> 0001839882-26-027296 <b>Size:</b> 632 KB

Share Buy Back - Daily Share Buy-Back Notice: S$2Bn Value Realisation Share Buy-back Programme